{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7346,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological signaling pathway map to justify combination therapy strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/24",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The diagram shows the RAS/MAPK signaling pathway. The table provides a breakdown of patient populations for specific indications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/25",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses two tables to demonstrate competitive advantage in potency and pharmacokinetics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/26",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The diagram shows the signaling pathway with specific drug targets highlighted.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/27",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide compares tumor volume reduction across two different CDX models (WiDr and RKO) using various treatment regimens.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/28",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes waterfall plot and swimmer plot for clinical trial results.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/29",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut 23MAR2023. TRAE = Treatment-related Adverse Event. EC = Encorafenib + Cetuximab.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/30",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a process-oriented flow to demonstrate clinical validation milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/31",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide highlights selectivity and potency, using arrows to indicate performance relative to the competitor.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/32",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented as tumor volume over time (days) with error bars representing SEM.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/33",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "Includes RECIST 1.1 criteria reference and specific patient history.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/34",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table compares 'ALL' vs 'Gr >= 3' adverse events for different dosing regimens.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/35",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The diagram shows the EGFR signaling pathway and the inhibitory effect of ERAS-801.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/36",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a stacked bar chart to show mutation incidence and a comparison table to contrast clinical outcomes across different indications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/37",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses Western blot data to demonstrate potency and a table to demonstrate pharmacokinetic superiority.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/38",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The chart is a Kaplan-Meier survival plot. The comparison shows ERAS-801 (blue line) outperforming standard EGFR inhibitors (Erlotinib, Lapatinib, Osimertinib) and vehicle control.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/39",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide displays four distinct survival plots (HK301, GS025, HK336, GS187) showing statistically significant survival improvements (***) with ERAS-801 treatment.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/40",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a waterfall plot to show individual model responses and pie charts to summarize efficacy across the total cohort vs. the specific EGFR-mutant/amplified subset.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/41",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a table format to communicate a product roadmap for clinical development.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/42",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/43",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 43,
          "beatId": "208ecfc2-9d23-4d32-944a-1372c9b19645",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Potential impact and investment thesis",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "Slides 43-44 present the investment thesis and potential impact",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": "Features the Erasca logo and a Lorenz attractor-style graphic.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/44",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 43,
          "beatId": "208ecfc2-9d23-4d32-944a-1372c9b19645",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Potential impact and investment thesis",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "Slides 43-44 present the investment thesis and potential impact",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a matrix-like layout to compare drug candidates by development stage and company, with a callout box for competitive advantages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/45",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "roadmap",
      "function": "prioritize",
      "notes": "The slide uses a bullseye/concentric circle framework to communicate strategic prioritization of clinical trials.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/46",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a contrast-based layout to frame the subject as a winner in a difficult therapeutic space.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/47",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses western blot data to demonstrate the superiority of ERAS-007 in a specific biological pathway context.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/48",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "other",
      "function": "illustrate_case",
      "notes": "Includes RECIST 1.1 criteria reference and patient progression note.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/49",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart displays individual patient responses to treatment, with bars colored by dosage level.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/50",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart displays individual patient treatment timelines, with markers for partial response, stable disease, and progressive disease.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/51",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data from HERKULES-1 study, cutoff 23 May 2022.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/52",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide uses a line chart to show concentration over time and a table to summarize key PK metrics (Cmax, Cmin, T>IC90, T<IC50) for five different dosing regimens.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/53",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}